Show simple item record

dc.contributor.authorLifestyle and Genetic Adaptations Study (OLaGA) Group
dc.contributor.authorNHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
dc.date.accessioned2022-05-19T23:20:16Z
dc.date.available2022-05-19T23:20:16Z
dc.date.issued2022
dc.identifier.citationNakao, T., Bick, A. G., Taub, M. A., Zekavat, S. M., Uddin, M. M., Niroula, A., Carty, C. L., Lane, J., Honigberg, M. C., Weinstock, J. S., Pampana, A., Gibson, C. J., Griffin, G. K., Clarke, S. L., Bhattacharya, R., Assimes, T. L., Emery, L. S., Stilp, A. M., Wong, Q., … NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. (2022). Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential. Science Advances.
dc.identifier.issn2375-2548
dc.identifier.pmid35385311
dc.identifier.doi10.1126/sciadv.abl6579
dc.identifier.urihttp://hdl.handle.net/10150/664473
dc.description.abstractHuman genetic studies support an inverse causal relationship between leukocyte telomere length (LTL) and coronary artery disease (CAD), but directionally mixed effects for LTL and diverse malignancies. Clonal hematopoiesis of indeterminate potential (CHIP), characterized by expansion of hematopoietic cells bearing leukemogenic mutations, predisposes both hematologic malignancy and CAD. TERT (which encodes telomerase reverse transcriptase) is the most significantly associated germline locus for CHIP in genome-wide association studies. Here, we investigated the relationship between CHIP, LTL, and CAD in the Trans-Omics for Precision Medicine (TOPMed) program (n = 63,302) and UK Biobank (n = 47,080). Bidirectional Mendelian randomization studies were consistent with longer genetically imputed LTL increasing propensity to develop CHIP, but CHIP then, in turn, hastens to shorten measured LTL (mLTL). We also demonstrated evidence of modest mediation between CHIP and CAD by mLTL. Our data promote an understanding of potential causal relationships across CHIP and LTL toward prevention of CAD. Copyright © 2022 The Authors, some rights reserved;
dc.language.isoen
dc.publisherAmerican Association for the Advancement of Science
dc.rightsCopyright © The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleMendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
dc.typeArticle
dc.typetext
dc.contributor.departmentDivision of Genetics, Genomics and Precision Medicine, University of Arizona
dc.identifier.journalScience Advances
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitleScience Advances
refterms.dateFOA2022-05-19T23:20:16Z


Files in this item

Thumbnail
Name:
sciadv.abl6579.pdf
Size:
497.2Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Except where otherwise noted, this item's license is described as Copyright © The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).